Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Nature Genetics
|
June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage
Zheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Cancer Discovery
|
September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
Brian Belmontes, Katherine K Slemmons, Chun Su, et al.
Nature Cancer
|
July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling
Steven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Nature
|
July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models
Dejan Juric, Kyung Song, Radia M Johnson, et al.
Science Translational Medicine
|
September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer
Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
Urszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature Communications
|
June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
Pratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Nature
|
May 6, 2026
Expanding the human proteome with microproteins and peptideins
Eric W Deutsch, Leron W Kok, Jonathan M Mudge, et al.
Nature
|
April 8, 2024
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Nature Genetics
|
June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage
Zheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Cancer Discovery
|
September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers
Brian Belmontes, Katherine K Slemmons, Chun Su, et al.
Nature Cancer
|
July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling
Steven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Nature
|
July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models
Dejan Juric, Kyung Song, Radia M Johnson, et al.
Science Translational Medicine
|
September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer
Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma
Urszula N Wasko, Jingjing Jiang, Alvaro Curiel-Garcia, et al.
Nature Communications
|
June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
Pratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Nature
|
May 6, 2026
Expanding the human proteome with microproteins and peptideins
Eric W Deutsch, Leron W Kok, Jonathan M Mudge, et al.
Nature
|
April 8, 2024
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N Wasko, Jingjing Jiang, Tanner C Dalton, et al.
Page
of 8